Findings

What do systematic reviews say?

5 questions · 6 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 16.7%Moderate 5 · 83.3%High 0 · 0%

Low molecular weight heparin vs UFH

Incidence of recurrent VTE1 after initial treatment (up to 15 days) · patients with venous thromboembolism.

LMWH probably leads to lower incidence of recurrent VTE1 after initial treatment (up to 15 days) compared with UFH (moderate certainty).

1 finding from 1 review

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial… 2017 · Cochrane Headline outcomes only
OR 0.69 [0.49, 0.98]
18 studies · 6238 participants
Moderate

Low molecular weight heparin vs UFH

Recurrent VTE · patients with venous thromboembolism.

LMWH probably leads to lower incidence of recurrent VTE1 (3 months compared with UFH (moderate certainty).

2 findings from 1 review

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial… 2017 · Cochrane Headline outcomes only
OR 0.71 [0.56, 0.9]
16 studies · 6661 participants
Moderate
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial… 2017 · Cochrane Headline outcomes only
OR 0.72 [0.59, 0.88]
22 studies · 9489 participants
Moderate

Low molecular weight heparin vs UFH

Reduction in thrombus size (pre‐ and post‐treatment venograms) · patients with venous thromboembolism.

LMWH may leads to lower reduction in thrombus size (pre‐ and post‐treatment venograms) compared with UFH (low certainty).

1 finding from 1 review

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial… 2017 · Cochrane Headline outcomes only
OR 0.71 [0.61, 0.82]
16 studies · 2909 participants
Low

Low molecular weight heparin vs UFH

Major bleeding · patients with venous thromboembolism.

LMWH probably leads to lower incidence of major haemorrhagic episodes (during initial treatment ‐… compared with UFH (moderate certainty).

1 finding from 1 review

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial… 2017 · Cochrane Headline outcomes only
OR 0.69 [0.5, 0.95]
25 studies · 8780 participants
Moderate

Low molecular weight heparin vs UFH

Overall mortality (end of · patients with venous thromboembolism.

LMWH showed no clear difference in overall mortality (end of compared with UFH (moderate certainty).

1 finding from 1 review

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial… 2017 · Cochrane Headline outcomes only
OR 0.84 [0.7, 1.01]
24 studies · 9663 participants
Moderate